PTK2 and pachyonychia congenita: Taken together, current evidence supports a model in which integrin α2β1 engagement of collagen-rich matrices activates FAK and JNK signaling cascades to promote invasion, EMT, and resistance to therapy in PC, positioning the α2β1–FAK–JNK axis as a promising target for therapeutic intervention.